🇺🇸 FDA
Patent

US 10016452

Fibromodulin formulation for reducing corneal scarring

granted A61KA61K31/728A61K38/1709

Quick answer

US patent 10016452 (Fibromodulin formulation for reducing corneal scarring) held by The Regents of the University of California expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/728, A61K38/1709, A61K45/06, A61K9/0048